Maria E. Martinez, Director at Mirati Therapeutics, Inc. (MRTX), sold 13,400 shares at $200.05 ($2.7M) on 2021-01-29, disclosed to the SEC on 2021-02-01.
Open-market sale of $2.7M MRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $197.14 | 50 | $10K | 0.4% |
| 2 | $198.48 | 250 | $50K | 1.8% |
| 3 | $200.05 | 719 | $144K | 5.3% |
| 4 | $200.05 | 719 | $144K | 5.3% |
| 5 | $200.90 | 462 | $93K | 3.4% |
| 6 | $200.90 | 462 |
| $93K |
| 3.4% |
| 7 | $201.99 | 960 | $194K | 7.1% |
| 8 | $201.99 | 960 | $194K | 7.1% |
| 9 | $203.43 | 1,579 | $321K | 11.8% |
| 10 | $203.43 | 1,579 | $321K | 11.8% |
| 11 | $204.43 | 1,205 | $246K | 9.0% |
| 12 | $204.43 | 1,205 | $246K | 9.0% |
| 13 | $205.26 | 975 | $200K | 7.3% |
| 14 | $205.26 | 975 | $200K | 7.3% |
| 15 | $206.63 | 1,100 | $227K | 8.3% |
| 16 | $207.83 | 200 | $42K | 1.5% |
| Total | $203.35 avg | 13,400 | $2.7M | 100% |